BioFactura Revenue and Competitors
Estimated Revenue & Valuation
- BioFactura's estimated annual revenue is currently $6.2M per year.
- BioFactura's estimated revenue per employee is $155,000
Employee Data
- BioFactura has 40 Employees.
- BioFactura grew their employee count by -2% last year.
BioFactura's People
Name | Title | Email/Phone |
---|---|---|
1 | Chairman the Board and Chief Medical Officer | Reveal Email/Phone |
2 | VP Scientific Affairs | Reveal Email/Phone |
3 | Director - Process and Drug Product Development | Reveal Email/Phone |
4 | Associate Director Manufacturing Operations | Reveal Email/Phone |
5 | Associate Director Upstream Process Development | Reveal Email/Phone |
6 | Associate Director Manufacturing Operations | Reveal Email/Phone |
7 | Director Quality and Regulatory Affairs | Reveal Email/Phone |
8 | Senior Manager Quality Control | Reveal Email/Phone |
9 | Sr Program Manager | Reveal Email/Phone |
10 | Senior Supply Chain Manager | Reveal Email/Phone |
BioFactura Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is BioFactura?
BioFactura develops and commercializes biodefense drugs, novel drugs, and high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFastâ„¢ Biomanufacturing Platform, the optimal choice for bringing these products to market with faster, lower cost, superior-quality manufacture. For over 10 years, BioFactura has been advancing life-saving medicines from the research bench to the patient using its innovative drug development and manufacturing technologies. Current and past programs include biodefense drugs against smallpox and Ebola, novel medicines for cancer, and low-cost/high-quality biosimilars for autoimmune and infectious diseases.
keywords:N/AN/A
Total Funding
40
Number of Employees
$6.2M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioFactura News
BioFactura, Inc. CEL-SCI Corporation; Chimerix, Inc. China Biologic Products, Inc. CJ HealthCare Corp. EpiVax, Inc. N &...
In addition to Amgen, Formycon, Samsung Bioepis, Bio-Thera Solutions, Hikma Pharmaceuticals, Alvotech, BioFactura, and NeuClone are in the...
BioFactura has completed the clinical phase of a pivotal Phase 1 trial for a biosimilar for Janssen's STELARA, which is a leading treatment for plaque...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.6M | 40 | 11% | N/A |
#2 | $9.3M | 40 | 5% | N/A |
#3 | $9.3M | 40 | 100% | N/A |
#4 | $8.9M | 41 | 14% | N/A |
#5 | $10.6M | 41 | 11% | N/A |